Slideset
View More
My take on the most important findings in RA prevention and treatment presented at the virtual EULAR 2020 E-Congress.
Paul Emery, MA, MD, FRCP
Physicians:
maximum of 0.25 AMA PRA Category 1 Credits™
Released: July 16, 2020
Expired:
No longer available for credit
My take on the most important findings regarding efficacy and safety of JAK inhibitors in RA presented at the virtual EULAR 2020 E-Congress.
Eric M. Ruderman, MD
Physicians:
maximum of 0.25 AMA PRA Category 1 Credits™
Released: July 16, 2020
Expired:
No longer available for credit
My thoughts on recent studies of RA and ILD, fatigue, and cancer presented at the virtual EULAR 2020 E-Congress.
Paul Emery, MA, MD, FRCP
Physicians:
maximum of 0.25 AMA PRA Category 1 Credits™
Released: August 24, 2020
Expired:
No longer available for credit
What to do in biologic-experienced patients with RA? Here’s my take.
Eric M. Ruderman, MD
Physicians:
maximum of 0.25 AMA PRA Category 1 Credits™
Released: August 27, 2020
Expired:
No longer available for credit
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.